Skip to main content

Advertisement

Springer Nature Link
Log in

Post-Translational Regulation of Cathepsin B, but not of Other Cysteine Cathepsins, Contributes to Increased Glioblastoma Cell Invasiveness In Vitro

  • Published:
Pathology & Oncology Research

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

Abstract

Cells that migrate away from a central tumour into brain tissue are responsible for inefficient glioblastoma treatment. This migratory behaviour depends partially on lysosomal cysteine cathepsins. Reportedly, the expression of cathepsins B, L and S gradually increases in the progression from benign astrocytoma to the malignant glioblastoma, although their specific roles in glioma progression have not been revealed. The aim of this study was to clarify their specific contribution to glioblastoma cell invasion. The differences between the matrix invading cells and non-invading core cells from spheroids derived from glioblastoma cell culture and from glioblastoma patients’ biopsies, and embedded in type I collagen, have been studied at the mRNA, protein and cathepsin activity levels. Analyses of the two types of cells showed that the three cathepsins were up-regulated post-translationally, their specific activities increasing in the invading cells. The cystatin levels were also differentially altered, resulting in higher ratio of cathepsins B and L to stefin B in the invading cells. However, using specific synthetic inhibitors and silencing strategies revealed that only cathepsin B activity was involved in the invasion of glioblastoma cells, confirming previous notion of cathepsin B as tumour invasiveness biomarker. Our data support the concept of specific roles of cysteine cathepsins in cancer progression. Finally the study points out on the complexity of protease regulation and the need to include functional proteomics in the systems biology approaches to understand the processes associated with glioma invasion and progression.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Canada)

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

Abbreviations

CatB:

cathepsin B

CatL:

cathepsin L

CatS:

cathepsin S

CysC:

cystatin C

ECM:

extracellular matrix

GBM:

Glioblastoma (multiformae)

PXA:

Pleomorphic xanthoastrocytoma

StefA:

stefin A

StefB:

stefin B

References

  1. Ohgaki H, Kleihues P (2005) Epidemiology and etiology of gliomas. Acta Neuropathol 109(1):93–108

    Article  PubMed  Google Scholar 

  2. Sathornsumetee S, Rich NJ (2006) New treatment strategies for malignant gliomas. Expert Rev Anticancer Ther 6(7):1087–1104

    Article  CAS  PubMed  Google Scholar 

  3. Rao JS (2003) Molecular mechanisms of glioma invasiveness: the role of proteases. Nat Rev Cancer 3(7):489–501

    Article  CAS  PubMed  Google Scholar 

  4. Demuth T, Berens M (2004) Molecular mechanisms of glioma cell migration and invasion. J Neurooncol 70(2):217–228

    Article  PubMed  Google Scholar 

  5. Wang W, Goswami S, Sahai E et al (2005) Tumour cells caught in the act of invading: their strategy for enhanced cell motility. Trends Cell Biology 15(3):138–145

    Article  CAS  Google Scholar 

  6. Sahai E (2005) Mechanisms of cancer cell invasion. Curr Opin Genet Dev 15(1):87–96

    Article  CAS  PubMed  Google Scholar 

  7. Mariani L, Beaudry C, McDonough WS et al (2001) Glioma cell motility is associated with reduced transcription of proapoptotic and proliferation genes: a cDNA microarray analysis. J Neurooncol 53(2):161–176

    Article  CAS  PubMed  Google Scholar 

  8. Demuth T, Rennert JL, Hoelzinger DB et al (2008) Glioma cells on the run- the migratory transcriptome of 10 human glioma cell lines. BMC Genomics 9:54

    Article  PubMed  Google Scholar 

  9. Berens ME, Rief MD, Loo MA, Giese A (1994) The role of extracellular matrix in human astrocytoma migration and proliferation studied in a microliter scale assay. Clin Exp Metastasis 12(6):405–415

    Article  CAS  PubMed  Google Scholar 

  10. Hoelzinger DB, Nakada M, Demuth T et al (2008) Autotaxin: a secereted autocrine/paracrine factor that promotes glioma invasion. J Neurooncol 86(3):297–309

    Article  CAS  PubMed  Google Scholar 

  11. Wolf K, Friedl P (2005) Functional imaging of pericellular proteolysis in cancer cell invasion. Biochemie 87(3–4):315–320

    Article  CAS  Google Scholar 

  12. Tu C, Ortega–Cava CF, Chen G et al (2008) Lysosomal cathepsins B participates in the podosome-mediated extracellular matrix degradation and invasion via secreted lysosomes in the v-Src fibroblasts. Cancer Res 86(22):9147–9156

    Article  Google Scholar 

  13. Lopez–Otin C, Matrisian LM (2007) Emerging roles of proteases in tumour suppression. Nature Rev Cancer 7(10):800–808

    Article  Google Scholar 

  14. Levičar N, Nuttall RL, Lah TT (2003) Proteases in brain tumour progression. Acta Neurochir (Wien) 145(9):825–838

    Article  Google Scholar 

  15. Lah TT, Duran Alonso MB, Van Noorden CJ (2006) Antiprotease therapy in cancer: hot or not? Expert Opin Biol Ther 6(3):257–279

    Article  CAS  PubMed  Google Scholar 

  16. Rempel SA, Rosenblum ML, Mikkelsen T et al (1994) CathepsinB expression and localization in glioma progression and invasion. Cancer Res 54(23):6027–6031

    CAS  PubMed  Google Scholar 

  17. Lah TT, Strojnik T, Levičar N et al (2000) Clinical and experimental studies of cysteine cathepsins and their inhibitors in human brain tumors. Int J Biol Markers 15(1):90–93

    CAS  PubMed  Google Scholar 

  18. Strojnik T, Kos J, Židanik B, Lah TT (1999) Cathepsin B immunohistochemical staining in tumour and endothelial cells is a new prognostic factor for survival in patients with brain tumours. Clin Cancer Res 5(3):559–567

    CAS  PubMed  Google Scholar 

  19. Strojnik T, Kavalar R, Trinkaus M, Lah TT (2005) Cathepsin L in glioma progression: comparison with cathepsin B. Cancer Detect Prev 29(5):448–455

    Article  CAS  PubMed  Google Scholar 

  20. Sivarapathi M, Yamamoto M, Nicolson GL et al (1996) Expression and immunohistochemical localization of cathepsin L during progression of human gliomas. Clin Exp Metastasis 14(1):27–34

    Article  Google Scholar 

  21. Flannery T, Gibson D, Mirakhur M et al (2003) The clinical significance of cathepsin S expression in human astrocytomas. Am J Pathol 163(1):175–182

    CAS  PubMed  Google Scholar 

  22. Flannery T, McQuaid S, McGoohan C et al (2006) Cathepsin S expression: An independent prognostic factor in glioblastoma tumours-A pilot study. Int J Cancer 119(4):854–860

    Article  CAS  PubMed  Google Scholar 

  23. Kos J, Lah TT (2006) Cystatins in cancer. In: Zerovnik E, Kopitar-Jerala N (eds) Human Stefins and Cystatins. Nova Science Publishers Inc, New York

    Google Scholar 

  24. Abrahamson M (1994) Cystatins. Methods Enzymol 244:685–700

    Article  CAS  PubMed  Google Scholar 

  25. Lignelid H, Collins VP, Jacobsson B (1997) Cystatin C and transthyretin expression in normal and neoplastic tissues of the human brain and pituitary. Acta Neuropathol 93(5):494–500

    Article  CAS  PubMed  Google Scholar 

  26. Nakabayashi H, Hara M, Shimuzu K (2005) Clinicopathologic significance of cystatin C expression in gliomas. Hum Pathol 36(9):1008–1015

    Article  CAS  PubMed  Google Scholar 

  27. Konduri SD, Yanamandra N, Siddique K et al (2002) Modulation of cystatin C expression impairs the invasive and tumorigenic potential of human glioblastoma cells. Oncogene 21(57):8705–8712

    Article  CAS  PubMed  Google Scholar 

  28. Bervar A, Zajc I, Sever B et al (2003) Invasiveness of transformed human breast epithelial cell lines is related to cathepsin B and inhibited by cysteine proteinase inhibitors. Biol Chem 384(3):447–455

    Article  CAS  PubMed  Google Scholar 

  29. Zajc I, Hreljac I, Lah T (2006) Cathepsin L affects apoptosis of glioblastoma cells: a potential implication in the design of cancer therapeutics. Anticancer Res 26(5A):3357-64

    Google Scholar 

  30. Hegedüs B, Marga F, Jakab K et al (2006) The Interplay of Cell-Cell and Cell-Matrix Interactions in the Invasive Properties of Brain Tumors. Biophys J 91(7):2708–2716

    Article  PubMed  Google Scholar 

  31. Corcoran A, De Ridder LI, Del Duca D et al (2003) Evolution of the brain tumour spheroid model: transcending current model limitations. Acta Neurochir (Wien) 145(9):819–824

    Article  CAS  Google Scholar 

  32. Rubenstein BM, Kaufman LJ (2008) The role of extracellular matrix in glioma invasion:a cellular potts model approach. Biophys J 95(12):5661–5680

    Article  CAS  PubMed  Google Scholar 

  33. Gondi CS, Kandhukuri N, Kondraganti S et al (2006) RNA interference–mediated simultaneous down-regulation of urokinase-type plasminogen activator receptor and cathepsin B induces caspase-mediated apoptosis in SNB 19 human glioma cells. Mol Cancer Ther 5(12):3197–3208

    Article  CAS  PubMed  Google Scholar 

  34. Gocheva V, Zeng W, Ke D et al (2006) Distinct role for cysteine cathepsin genes in multistage tumourigenesis. Genes Dev 20(5):543–556

    Article  CAS  PubMed  Google Scholar 

  35. Reinheckel T, Gocheva V, Peters C, Joyce JA (2008) Roles of cysteine proteases in tumour progression: Analysis of cysteine cathepsins knockout mice in cancer models. In: Edwards D, Hoyer-Hansen G, Blasi F, Sloane BF (eds) The Cancer Degradome. Springer Science + Business Media, New York

  36. Lakka C, Gondi CS, Yanamandra N et al (2004) Inhibition of cathepsin B and MMP-9 gene expression in glioblastoma cell line via RNA interference reduces tumour cell invasion, tumour growth and angiogenesis. Oncogene 23(27):4681–4689

    Article  CAS  PubMed  Google Scholar 

  37. Premzl A, Zavasnik-Bergant V, Turk V, Kos J (2003) Intracellular and extracellular cathepsin B facilitate invasion of MCF-10A neoT cells through reconstituted extracellular matrix in vitro. Exp Cell Res 283(2):206–214

    Article  CAS  PubMed  Google Scholar 

  38. Klose A, Wilbrand-Hennes A, Zigrino P et al (2006) Contact of high-invasive, but not low-invasive, melanoma cells to native collagen I induces the release of mature cathepsin B. Int J Cancer 118(11):2735–2743

    Article  CAS  PubMed  Google Scholar 

  39. Podgorski I, Linebough BE, Sameni M et al (2005) Bone microenvironment modulates expression and activity of cathepsin B in prostate cancer. Neoplasia 7(3):207–223

    Article  CAS  PubMed  Google Scholar 

  40. Sameni M, Dosescu J, Sloane BF (2001) Imaging proteolysis by living human glioma cells. Biol Chem 382(5):785–788

    Article  CAS  PubMed  Google Scholar 

  41. Zhu DM, Uckun FM (2000) Z-Phe-Gly-NHO-Bz, an inhibitor of cysteine cathepsins, induces apoptosis in human cancer cells. Clin Cancer Res 6(5):2064–2069

    CAS  PubMed  Google Scholar 

  42. Felbor U, Kesseler B, Mothes W et al (2002) Neuronal loss and brain atrophy in mice lacking cathepsins B and L. Proc Natl Acad Sci USA 99(12):7883–7888

    Article  CAS  PubMed  Google Scholar 

  43. Levičar N, Dewey RA, Daley E et al (2003) Selective supression of cathepsin L by antisense cDNA impairs human brain tumor cell invasion in vitro and promotes apoptosis. Cancer Gene Ther 10(2):141–151

    Article  PubMed  Google Scholar 

  44. Castino R, Pace D, Démoz M et al (2002) Lysosomal proteases as potential targets for the induction of apoptotic cell death in human neuroblastomas. Int J Cancer 97(6):775–779

    Article  CAS  PubMed  Google Scholar 

  45. Bellail AC, Hunter SB, Brat DJ et al (2004) Microregional extracellular matrix heterogeneity in brain modulates glioma cell invasion. Int J Biochem Cell Biol 36(6):1046–1069

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We are grateful to Seyed Y. Ardebili, M.D., for providing us with human tumour samples, to Dr. Janko Kos for providing the ELISA kits and primary antibodies, to Dr. Nobuhiko Katunuma for providing Clik 148, to Dr. Irena Zajc and Dr. Simon Caserman for their scientific and technical contributions to this work, and to Dr. Roger Pain for critical reading of the manuscript.

Author information

Authors and Affiliations

  1. Department of Genetic Toxicology and Cancer Biology, National Institute of Biology, Ljubljana, Slovenia

    Boris Gole, María Beatriz Durán Alonso & Tamara Lah

  2. Department of Neurosurgery, University Clinical Centre, Ljubljana, Slovenia

    Vincenc Dolenc

  3. National Institute of Biology, Večna pot 111, Ljubljana, SI-1000, Slovenia

    Boris Gole

Authors
  1. Boris Gole
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. María Beatriz Durán Alonso
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Vincenc Dolenc
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Tamara Lah
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Boris Gole.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gole, B., Durán Alonso, M.B., Dolenc, V. et al. Post-Translational Regulation of Cathepsin B, but not of Other Cysteine Cathepsins, Contributes to Increased Glioblastoma Cell Invasiveness In Vitro . Pathol. Oncol. Res. 15, 711–723 (2009). https://doi.org/10.1007/s12253-009-9175-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12253-009-9175-8

Keywords

Search

Navigation